I tripled down into earnings and am not disappointed with the market's response. I suspect that the co.'s transition to autonomous sales in the EU will boost revenue beginning in 2 quarters and profitability is one year away. Look to one of the bigger players to start sniffing around for a buyout in 24-36 months. By that time, we will have north of $500 million in annual sales and a market cap north of 1.5 billion, IMO.
I would be thrilled with those numbers, but they might be too optimistic. Mgmt seems to be spending a lot of $$ on SG&A, but the number of at home patients seems to be stuck at 5K-6K. Not sure they're getting much bang for their buck there, but hopefully the new features (nocturnal, high flow, etc) will help. I think they could be profitable now, but with their spending habits, it might take a while longer than your one year window.